Registration will be held in the Foyer of the Cheung Kung Hai Conference Center.
| Tuesday, November 13 |
Early Arrivals: |
1:00 PM to 5:00 PM |
| Wednesday, November 14 |
|
7:30 AM to 5:00 PM |
| Thursday, November 15 |
|
7:30 AM to 5:00 PM |
| Friday, November 16 |
|
7:30 AM to Noon |
November 14, 2007
Session 1: New Directions in Clinical Research: The Implications for Treatment
| Moderator: |
Webster K. Cavenee, Ph.D., Ludwig Cancer Institute for Cancer Research
|
| Speakers: |
Brian Leyland-Jones, M.D., Ph.D., Emory-Winship Cancer Center
Waun Ki Hong, M.D., M.D. Anderson Cancer Center
Edward Chu, M.D., Yale Cancer Center
Y.L. Kwong, M.D., The University of Hong Kong
Dialogue: Moderator |
Morning Coffee/Tea Break
Session 2: New Paradigms in Cancer Research: The Impact on Emerging Discovery
| Moderator: |
Richard B. Gaynor, M.D., Ph.D., Eli Lilly and Company |
| Speakers: |
Webster K. Cavenee, Ph.D., Ludwig Cancer Institute for Cancer Research
Peter Friedl, M.D., Ph.D., University of Würzburg
Mary-Claire King, Ph.D., University of Washington
Dialogue: Moderator
|
Lunch Break
Session 3: Targeted Cancer Therapies and Personalized Medicine
| Moderator: |
Yung-Chi Cheng, Ph.D., Yale School of Medicine |
| Speakers: |
Mien-Chie Hung, Ph.D, M.D. Anderson Cancer Center
Michael T. Berens, Ph.D., Translational Genomics Research Institute
Ronnie Poon, Ph.D., The University of Hong Kong
Richard B. Gaynor, M.D., Ph.D., Eli Lilly and Company
Paul Shimmel, Ph.D., Scripps Research Institute
Dialogue: Moderator |
Afternoon Coffee and Tea Break
Session 4: Globalization of Traditional Chinese Medicine
| Moderator: |
Edward Chu, M.D., Yale Cancer Center |
| Speakers: |
Yung-Chi Cheng, Ph.D., Yale School of Medicine
Allan Sik-yin Lau, M.D., The University of Hong Kong
Ricky Y.K. Man, Ph.D., The University of Hong Kong
Dialogue: Moderator |
November 15, 2007
Session 5: Achievements in Global Collaborations
| Moderator: |
Yi Michael Wang, M.D., Ph.D., M.B.A., National Foundation for Cancer Research |
| Speakers: |
David L. Edwards, Ph.D., Avolix Pharmaceuticals
Wei Zhang, Ph.D., M.D., Anderson Cancer Center
David G.P. Allan, YM Biosciences
Xiang-Lei Yang, Ph.D., Scripps Research Institute
Ke-Xin Chen, Tianjin Medical Hospital
Dialogue: Moderator
Note: Additional respondents may be added to participate in the Dialogue
|
Lunch Break
Session 6: Opportunities in the Life Sciences
| Moderator: |
Sujuan Ba, Ph.D., Asian Fund for Cancer Research |
| Speakers: |
Richard B. Gaynor, M.D., Ph.D., Eli Lilly and Company
Paul Shimmel, Ph.D., Scripps Research Institute
David G.P. Allan, YM Biosciences
Dajun Yang
Dialogue: Moderator
|
November 15 - 16, 2006
Poster Sessions and Oral Presentations
Annual HKICC Lecture:
Clinical Implications of Recent Developments in
Ovarian and Breast Cancer Research
Mary-Claire King, Ph.D.
University of Washington
State-of-the-Art Lectures:
Clinical Interventions in Cancer Metastasis
New Developments in Radiation Oncology
Prevention of Cervical Cancer
Symposium:
Recent Developments in Brain Cancer Research
Webster K. Cavenee, Ph.D.
Ludwig Institute For Cancer Research
Workshop:
Psychosocial Aspects of Cancer Care
Medical Session:
New Options in Pediatric Oncology
Poster Sessions and Oral Poster Presentations
November 16, 2007
Annual CCR Lecture:
Clinical Implications of the Revolution in Cancer Diagnostics
Brian Leyland-Jones, M.D., Ph.D.
Emory-Winship Cancer Center
State-of-the-Art Lectures:
Ovarian and Breast Cancer
Pediatric Cancers
Emerging Options from Immunotherapy and Virotherapy Research
Angiogenesis and Antiangiogenic Therapeutics
Symposium:
From the Genetic Code to Disease: It's All Connected
Paul Schimmel, Ph.D.
Scripps Research Institute
Workshop:
New Approaches in Oncology Nursing and Family Support
Medical Sessions:
Research Impact on Cancer Care for the Physician
Poster Sessions and Oral Poster Presentations